Clinical Trials Browser

Completed × NETWORK × Neurotoxicity Syndromes × Clear all

NCT01399372 2023-07-20

Rituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma

Phase 2 Completed

91 enrolled 17 charts

Lymphoma, Radiation Injuries, Neurotoxicity Syndromes

NCT00566852 2017-08-21

Memantine in Preventing Side Effects in Patients Undergoing Whole-Brain Radiation Therapy for Brain Metastases From Solid Tumors

Phase 3 Completed

554 enrolled 12 charts

Brain Neoplasms, Neoplasm Metastasis, Neurotoxicity Syndromes

NCT00775645 2017-08-14

S0715: Acetyl-L-Carnitine in Preventing Neuropathy in Women With Stage I, II, or IIIA Breast Cancer Undergoing Chemo

Phase 3 Completed

437 enrolled 14 charts

Breast Neoplasms, Fatigue, Neurotoxicity Syndromes

NCT00437060 2017-07-21

Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia

Neurotoxicity Syndromes

NCT01763710 2016-03-29

neurabrax

Phase 2 Completed

Breast Neoplasms, Neurotoxicity Syndromes

NCT00028509 2014-02-13

Brain Function in Children Previously Treated on Clinical Trials POG-9605 and POG-9201

Neurotoxicity Syndromes

NCT00085176 2014-01-30

Neurobehavioral Complications in Children Who Were Previously Treated With Steroids and Intrathecal Therapy for Acute Lymphoblastic Leukemia

Other hematologic neoplasm

Leukemia, Neurotoxicity Syndromes

NCT00058071 2013-07-09

Amifostine in Treating Peripheral Neuropathy in Patients Who Have Received Chemotherapy for Cancer

Phase 3 Completed

Hydatidiform Mole, Peripheral Nervous System Diseases, Neurotoxicity Syndromes, Gestational Trophoblastic Disease